Skip to content
Open access

Evaluation of Urinary Circulating Tumor DNA to Detect Minimal Residual Disease in Patients with High-Risk Non-Muscle Invasive Bladder Cancer

Sep 2026 · medRxiv · 0 citations
Medicine
Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.